(IDYA) - Management Comments

(IDYA) – Management Comments

Nov 15, 2021 06:05 AM IDEAYA Biosciences (IDYA) Reports Q3 Results; Issues Business Update
May 10, 2021 06:13 AM IDEAYA Biosciences (IDYA) Reports Dose Expansion in Phase 1/2 Study of Darovasertib and Crizotinib Combination Based on Early Clinical Efficacy in First Combination Cohort
Apr 15, 2021 06:05 AM
Feb 8, 2021 06:05 AM
Jan 11, 2021 06:07 AM
Jan 5, 2021 06:00 AM
Sep 24, 2020 06:04 AM
Aug 4, 2020 06:21 AM
Jul 16, 2020 06:11 AM
Jul 9, 2020 06:01 AM
Jun 30, 2020 06:01 AM
Mar 18, 2020 06:20 AM
Mar 18, 2020 06:18 AM
Dec 18, 2019 06:13 AM
Dec 9, 2019 06:14 AM
Nov 20, 2019 06:04 AM
Oct 31, 2019 04:44 PM
Jul 9, 2019 06:09 AM